| Spontaneous assembly of subnanometre-ordered domains in the ligand shell of monolayer-protected nanoparticles AM Jackson, JW Myerson, F Stellacci Nature materials 3 (5), 330-336, 2004 | 697 | 2004 |
| Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude JS Brenner, DC Pan, JW Myerson, OA Marcos-Contreras, CH Villa, ... Nature communications 9 (1), 2684, 2018 | 386 | 2018 |
| Microphysiological engineering of self-assembled and perfusable microvascular beds for the production of vascularized three-dimensional human microtissues J Paek, SE Park, Q Lu, KT Park, M Cho, JM Oh, KW Kwon, Y Yi, JW Song, ... ACS nano 13 (7), 7627-7643, 2019 | 259 | 2019 |
| Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier OA Marcos-Contreras, CF Greineder, RY Kiseleva, H Parhiz, LR Walsh, ... Proceedings of the National Academy of Sciences 117 (7), 3405-3414, 2020 | 187 | 2020 |
| Nanoparticle properties modulate their attachment and effect on carrier red blood cells DC Pan, JW Myerson, JS Brenner, PN Patel, AC Anselmo, S Mitragotri, ... Scientific Reports 8 (1), 1615, 2018 | 144 | 2018 |
| Targeting drug delivery in the vascular system: Focus on endothelium PM Glassman, JW Myerson, LT Ferguson, RY Kiseleva, VV Shuvaev, ... Advanced drug delivery reviews 157, 96-117, 2020 | 143 | 2020 |
| The role of nanostructure in the wetting behavior of mixed-monolayer-protected metal nanoparticles A Centrone, E Penzo, M Sharma, JW Myerson, AM Jackson, N Marzari, ... Proceedings of the National Academy of Sciences 105 (29), 9886-9891, 2008 | 138 | 2008 |
| Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE) H Parhiz, JS Brenner, PN Patel, TE Papp, H Shahnawaz, Q Li, R Shi, ... Journal of Controlled Release 344, 50-61, 2022 | 135 | 2022 |
| Gadolinium‐modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging AM Neubauer, J Myerson, SD Caruthers, FD Hockett, PM Winter, J Chen, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2008 | 127 | 2008 |
| Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis J Myerson, L He, G Lanza, D Tollefsen, S Wickline Journal of Thrombosis and Haemostasis 9 (7), 1292-1300, 2011 | 118 | 2011 |
| Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation Nature Nanotechnology, 2021 | 112* | 2021 |
| Flexible nanoparticles reach sterically obscured endothelial targets inaccessible to rigid nanoparticles JW Myerson, B Braender, O Mcpherson, PM Glassman, RY Kiseleva, ... Advanced Materials 30 (32), 1802373, 2018 | 105 | 2018 |
| Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function KP Bibee, YJ Cheng, JK Ching, JN Marsh, AJ Li, RM Keeling, ... The FASEB Journal 28 (5), 2047, 2014 | 105 | 2014 |
| Non-affinity factors modulating vascular targeting of nano-and microcarriers JW Myerson, AC Anselmo, Y Liu, S Mitragotri, DM Eckmann, ... Advanced drug delivery reviews 99, 97-112, 2016 | 87 | 2016 |
| Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions S Omo‐Lamai, ME Zamora, MN Patel, J Wu, J Nong, Z Wang, A Peshkova, ... Advanced Materials 36 (26), 2312026, 2024 | 86 | 2024 |
| Programmable nanoparticle functionalization for in vivo targeting H Pan, JW Myerson, L Hu, JN Marsh, K Hou, MJ Scott, JS Allen, G Hu, ... The FASEB Journal 27 (1), 255, 2013 | 81 | 2013 |
| Unintended effects of drug carriers: Big issues of small particles H Parhiz, M Khoshnejad, JW Myerson, E Hood, PN Patel, JS Brenner, ... Advanced drug delivery reviews 130, 90-112, 2018 | 80 | 2018 |
| Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke Molecular Therapy, 2024 | 64* | 2024 |
| Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain OA Marcos-Contreras, JS Brenner, RY Kiseleva, V Zuluaga-Ramirez, ... Journal of controlled release 301, 54-61, 2019 | 59 | 2019 |
| Combating complement's deleterious effects on nanomedicine by conjugating complement regulatory proteins to nanoparticles Z Wang, ED Hood, J Nong, J Ding, OA Marcos‐Contreras, PM Glassman, ... Advanced Materials 34 (8), 2107070, 2022 | 58 | 2022 |
